Clinical trials
Completed Observational Central Nervous System Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2004 | 2 |
| 2005 | 5 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 2 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 5 |
| 2018 | 2 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 47 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Oncology Group | 7 |
| Mayo Clinic | 5 |
| National Cancer Institute (NCI) | 4 |
| Alliance for Clinical Trials in Oncology | 3 |
| Bracco Diagnostics, Inc | 3 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2 |
| University of Colorado, Denver | 2 |
| Wake Forest University Health Sciences | 2 |
| Ann & Robert H Lurie Children's Hospital of Chicago | 1 |
| Arbor Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Central Nervous System Neoplasms | 47 |
| Brain Neoplasms | 20 |
| Astrocytoma | 13 |
| Medulloblastoma | 10 |
| Oligodendroglioma | 10 |
| Glioblastoma | 9 |
| Glioma | 8 |
| Gliosarcoma | 7 |
| Choroid Plexus Neoplasms | 6 |
| Neoplasms | 6 |
Trials
Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.